Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage
See all results for  

bharat biotech

Money Control
India#39;s first COVID-19 vaccine COVEXIN: Here is everything you want to know
COVAXIN is India’s #39;first#39; indigenous COVID-19 vaccine, developed by Hyderabad-based Bharat Biotech in collaboration with ICMR and NIV
 Money Control2 days ago
India’s first Covid-19 vaccine candidate by Hyderabad-based Bharat Biotech set for trials
India’s first Covid-19 vaccine candidate by Hyderabad-based Bharat Biotech set for trials
 Times of India2 days ago
DNA
Bharat Biotech's indigenous COVID-19 vaccine 'COVAXIN'...
Bharat Biotech's indigenous COVID-19 vaccine 'COVAXIN'...
 DNA2 days ago
Covid vaccine candidate by Hyd co set for trials
India’s first Covid-19 vaccine candidate Covaxin, developed by Hyderabad-based Bharat Biotech in collaboration with the National Institute of Virology (NIV), has received Drug Controller General of India (DCGI) approval for phase I and II human trials.
 Times of India2 days ago
India's First Indigenous Covid-19 Vaccine COVAXIN Gets Approval for Human Clinical Trials
COVAXIN has been developed by Bharat Biotech in collaboration with ICMR and NIV and has got the nod for human clinical trials from the Drug Controller General of India.
 News182 days ago
Hindustan Times
Vaccine by Bharat Biotech first to get human trials nod
The strains of Sars-CoV-2 that causes Covid-19 was isolated by ICMR-NIV and transferred to Bharat Biotech in May. Scientists have managed to isolate and culture 11 strains that can be used to develop vaccines and aid research. india Updated: Jun 30, 2020 ...
 Hindustan Times2 days ago
Economic Times
Bharat Biotech’s Covid vaccine gets DCGI nod for clinical trials
strain was isolated in NIV and transferred to Bharat Biotech, which has developed the indigenous, inactivated vaccine at its biosafety level-3 (BSL-3) high containment facility located in Genome Valley in Hyderabad outskirts. By CR Sukumar , ET Bureau | Last ...
 Economic Times2 days ago
Times of India
Bharat Biotech develop's India's first Covid-19 vaccine candidate with ICMR-NIV, gets DCGI nod for human trials
Bharat Biotech develop's India's first Covid-19 vaccine candidate with ICMR-NIV, gets DCGI nod for human trials Bharat Biotech develop's India's first Covid-19 vaccine candidate with ICMR-NIV, gets DCGI nod for human trials Facebook Twitter Linkedin ...
 Times of India2 days ago
India’s 'First' Indigenous COVID-19 Vaccine COVAXIN Gets Approval For Human Clinical Trial
The country's 'first' indigenous COVID-19 vaccine COVAXIN, developed by city-based Bharat Biotech in collaboration with ICMR and NIV, has got the nod for human clinical trials from the Drug Controller General of India, the company said on Monday. The Phase I ...
 News182 days ago
India's first COVID-19 vaccine gets nod for human trials
The country's 'first' indigenous COVID-19 vaccine COVAXIN, developed by Hyderabad-based Bharat Biotech in collaboration with Indian Council of Medical Research and National Institute of Virology, has got the nod for human clinical trials from the Drug Controller General of India, the company said on Monday. The Phase I and Phase II clinical trials of the vaccine for SARS-CoV-2, approved after pre-clinical studies demonstrated safety and immune response, would start across the country next ...
 Rediff.com2 days ago
First Post.com
India's first COVID-19 vaccine, COVAXIN, by Bharat Biotech gets DCGI nod for human clinical trials
India's first COVID-19 vaccine, COVAXIN, by Bharat Biotech gets DCGI nod for human clinical trials
 First Post.com2 days ago
Money Control
Bharat Biotech#39;s COVID-19 vaccine gets DCGI nod to conduct human trials
Bharat Biotech is developing COVID-19 vaccine in collaboration with the Indian Council of Medical Research (ICMR) and National Institute of Virology (NIV), Pune.
 Money Control2 days ago
Bharat Biotech develops India's first vaccine candidate for Covid-19
2020 10:16:34 PM Hyderabad, Jun 29 (IANS): Leading vaccine maker Bharat Biotech on Monday announced that it has successfully developed Covaxin, India's first vaccine candidate for Covid-19, in collaboration with the Indian Council of Medical Research (ICMR) ...
 Daiji World2 days ago
DCGI approves Bharat Biotech’s Covid-19 vaccine for human clinical trials
Bharat Biotech has developed India’s first vaccine candidate for Covid-19, Covaxin, in collaboration with the Indian Council of Medical Research (ICMR
 Hindu Business Line2 days ago
Bharat Biotech secures funding from CEPI for developing Chikungunya vaccine
Bharat Biotech#39;s BBV87 vaccine is an inactivated whole virion vaccine based on a strain derived from an East, Central, South African (ECSA) genotype.
 Money Control4 weeks ago
Coronavirus vaccine update: Positive development for Bharat Biotech COVID-19 vaccine, Moderna moves to second phase of human trials
Trending in Entertainment
 Times of India4 weeks ago
Hindustan Times
Bharat Biotech ties up with US varsity for Covid vaccine
Bharat Biotech ties up with US varsity for Covid vaccine india Updated: May 20, 2020 23:43 IST Bharat Biotech has partnered with the US-based Thomas Jefferson University (TJU) to develop its experimental vaccine Coravax against Covid-19 under the accelerated ...
 Hindustan Times1 month ago
News18
Human Trials of Bharat Biotech's COVID-19 Nasal-drop Vaccine to Begin in 4 Months: Report
Issued in public interest by HDFC Life. HDFC Life Insurance Company Limited (Formerly HDFC Standard Life Insurance Company Limited) (“HDFC Life”). CIN: L65110MH2000PLC128245, IRDAI Reg. No. 101 . The name/letters "HDFC" in the name/logo of the company ...
 News182 months ago
Bharat Biotech's Covid-19 vaccine likely to begin human trials by July
Bharat Biotech is collaborating with virologists at the University of Wisconsin–Madison and the vaccine company, FluGen, for the project.
 Hindustan Times2 months ago
Economic Times
Bharat Biotech in tie-up to develop a Covid vaccine
Bharat Biotech said on Friday that it has partnered with the University of Wisconsin Madison and US-based company FluGen to develop a vaccine, Coro-Flu, against Covid-19.
 Economic Times2 months ago
Rediff.com
PM reviews preparations for vaccination against COVID-19
Prime Minister Narendra Modi on Tuesday chaired a high-level meeting to review the preparations being undertaken for vaccination against COVID-19, as and when a vaccine is available. The PM directed officials to evaluate various technology tools to ensure efficient and timely vaccination in due course of time. He also emphasised that detailed planning for such large scale vaccination should be undertaken immediately. The current status of Indian and global vaccine development efforts was also ...
 Rediff.com2 days ago
Rediff.com
'COVID-19 vaccine will be made in India'
'I can say with confidence that any future SARS-CoV-2 vaccine, developed anywhere in the world, would have to be manufactured in India, if it is to be affordable and of high quality.' IMAGE: A laboratory at the Serum Institute of India, the world's largest maker of vaccines, which is working on vaccines against the coronavirus disease. Photograph: Euan Rocha/Reuters   It will finally only be a vaccine that will defeat COVID-19. And put a halt to its victorious sweep through 2020 and ...
 Rediff.com2 weeks ago
COVID-19 vaccine development at early stage in India: Experts
As Indian firms scramble to develop a vaccine for coronavirus, experts feel that research in the country is still at a nascent stage and any concrete breakthrough is not likely within a year. The Indian government and private firms have stepped up efforts to develop a vaccine to halt the spread of COVID-19 which has claimed over 3,700 lives with more than 1,25,000 cases in the country. PM CARES Fund Trust has decided to allocate Rs 100 crore for support to coronavirus vaccine development ...
 Rediff.com1 month ago
Rediff.com
How long before the world gets a COVID-19 vaccine?
More than 2 million people have been diagnosed with coronavirus across the world, and the pharmaceutical industry is pulling out all stops to find potential treatments and vaccines for the global pandemic. According to the World Health Organization, there are now more than 70 potential vaccines under development, with some already in clinical trials. IMAGE: Andressa Parreiras, Biomedic, and Larissa Vuitika, biologist, work in a laboratory during the extraction of the virus genetic material in ...
 Rediff.com2 months ago
Money Control
India#39;s first COVID-19 vaccine COVAXIN: Here is everything you want to know
COVAXIN is India’s #39;first#39; indigenous COVID-19 vaccine, developed by Hyderabad-based Bharat Biotech in collaboration with ICMR and NIV
 Money Control2 days ago
India's first Covid-19 vaccine gets DCGI nod
Hyderabad vaccine major Bharat Biotech on Monday announced that its COVAXIN has become the country’s first Covid vaccine candidate approved by the Drug Controller General of India and the first vaccine that has got the approval for phase I and II human ...
 Times of India2 days ago

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Happening by Location Click on any location on map to view latest news by location